Cargando…

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus responsible for numerous outbreaks. Chikungunya can cause debilitating acute and chronic disease. Thus, the development of a safe and effective CHIKV vaccine is an urgent global health priority. This study evaluated the effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roques, Pierre, Fritzer, Andrea, Dereuddre-Bosquet, Nathalie, Wressnigg, Nina, Hochreiter, Romana, Bossevot, Laetitia, Pascal, Quentin, Guehenneux, Fabienne, Bitzer, Annegret, Corbic Ramljak, Irena, Le Grand, Roger, Lundberg, Urban, Meinke, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431671/ https://www.ncbi.nlm.nih.gov/pubmed/35700051 http://dx.doi.org/10.1172/jci.insight.160173

Ejemplares similares

Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial
por: Lazarus, Rajeka, et al.
Publicado: (2022)

EFFECTS OF HOMOLOGOUS AND HETEROLOGOUS BOOSTER VACCINATIONS OF THE INACTIVATED DUAL-ADJUVANTED VACCINE VLA2001 AGAINST COVID-19 INCLUDING VARIANTS OF CONCERN: A PHASE 3 RANDOMIZED CLINICAL TRIAL
por: Wressnigg, N., et al.
Publicado: (2023)

Mucosal application of the broadly neutralizing antibody 10-1074 protects macaques from cell-associated SHIV vaginal exposure
por: Suphaphiphat, Karunasinee, et al.
Publicado: (2023)

Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults
por: Lazarus, Rajeka, et al.
Publicado: (2022)

Hieronymus Fracastorius 1483—1553
por: Banerjee, A. K.
Publicado: (1988)

The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes
por: Comstedt, Pär, et al.
Publicado: (2017)

Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque
por: Olivo, Anaëlle, et al.
Publicado: (2022)

Challenges in Surveillance for Chikungunya Virus (CHIKV) Infection
por: Lucero-Obusan, Cynthia A., et al.
Publicado: (2015)

La imprenta en México, 1553-1820
por: Medina, José Toribio, 1852-1930
Publicado: (1952)

MIL-STD-1553-B and the Next Generation Conference
Publicado: (1989)

Male Visceral Figure from the 1553 Edition of Vasse
Publicado: (1939)

Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion
por: Bourry, Olivier, et al.
Publicado: (2010)

Discovery of Mosquito Saliva MicroRNAs during CHIKV Infection
por: Maharaj, Payal D., et al.
Publicado: (2015)

Impact of CHIKV Replication on the Global Proteome of Aedes albopictus Cells
por: Kumar, Ramesh, et al.
Publicado: (2022)

Peptide aptamer-based time-resolved fluoroimmunoassay for CHIKV diagnosis
por: Liu, Tonggong, et al.
Publicado: (2023)

Hunted Heretic; The Life and Death of Michael Servetus 1511-1553
por: Kilgour, Frederick G.
Publicado: (1954)

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
por: Schneider, Martina, et al.
Publicado: (2023)

Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture
Publicado: (1992)

Síntesis e índice de los mandamientos virreinales 1548-1553
por: Gerhard, Peter, 1920-
Publicado: (1992)

Description of the MIL1553-G64 communications package: Version 6
por: Brummer, P J
Publicado: (1986)

Datasets of RT spoofing attacks on MIL-STD-1553 communication traffic
por: Yahalom, Ran, et al.
Publicado: (2019)

1553. Efficacy and Safety of Dalbavancin and Oritavancin in the Treatment of Gram-Positive Infections
por: Brown, Vanessa, et al.
Publicado: (2020)

Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins
Publicado: (1995)

Cell adhesion and migration are regulated at distinct stages of thymic T cell development: the roles of fibronectin, VLA4, and VLA5
Publicado: (1996)

ROSAT/ASCA/VLA studies of solar proxies
por: Güdel, M, et al.
Publicado: (1996)

A klystron-modulator interlock and fault acquisition system using G-64, VME AND MIL-1553-B standards: using G-64, VME AND MIL-1553-B standards
por: Campbell, A, et al.
Publicado: (1994)

Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)
por: Broeckel, Rebecca, et al.
Publicado: (2015)

Controls of the large European LEP and SPS accelerators based on the 1553 field bus
por: Rausch, R
Publicado: (1990)

Chikungunya virus (CHIKV) inhibitors from natural sources: a medicinal chemistry perspective
por: Bhakat, Soumendranath, et al.
Publicado: (2015)

Genomic surveillance of the Chikungunya Virus (CHIKV) in Northeast Brazil after the first outbreak in 2014
por: Rodrigues, Ayslany Melo, et al.
Publicado: (2020)

The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: A systematic review and meta-analysis
por: Li, Zhihui, et al.
Publicado: (2021)

Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need
por: Cherian, Neil, et al.
Publicado: (2023)

The Innate Immune Response in DENV- and CHIKV-Infected Placentas and the Consequences for the Fetuses: A Minireview
por: de Andrade Vieira Alves, Felipe, et al.
Publicado: (2023)

1553. Infectious Complications Following Hematopoietic Cell Transplantation in Patients With Primary Immunodeficiency Diseases
por: Vora, Surabhi, et al.
Publicado: (2018)

Attenuation and Stability of CHIKV-NoLS, a Live-Attenuated Chikungunya Virus Vaccine Candidate
por: Abeyratne, Eranga, et al.
Publicado: (2018)

Simultaneous Circulation of DENV, CHIKV, ZIKV and SARS-CoV-2 in Brazil: an Inconvenient Truth
por: Silva, Severino Jefferson Ribeiro da, et al.
Publicado: (2020)

Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice
por: Zhao, Zhimin, et al.
Publicado: (2021)

Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis
Publicado: (1991)

CNS accumulation of regulatory B cells is VLA-4-dependent
por: Lehmann-Horn, Klaus, et al.
Publicado: (2016)

Integrin-directed antibody-based immunotherapy: focus on VLA-4
por: Savino, Wilson, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjdr2hoti1qvovrk81gppjco11